[Type 2 diabetes mellitus with histological finding of nonalcoholic steatohepatitis following combination therapy with interferon and ribavirin for chronic hepatitis C].
Yagi
Norio
N
Department of Internal Medicine, Kohan Hospital.
Uchikoga
Osamu
O
Nishumi
Tomoko
T
Shibutani
Yuki
Y
Fukunaga
Kaoru
K
Yagi
Norio
N
Morita
Munetaka
M
Tani
Satoshi
S
Murao
Shinichi
S
D000328:Adult; D000998:Antiviral Agents / Q000008:administration & dosage / Q000009:adverse effects*; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology*; D003924:Diabetes Mellitus, Type 2 / Q000139:chemically induced*; D005234:Fatty Liver / Q000139:chemically induced*; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D007372:Interferons / Q000008:administration & dosage / Q000009:adverse effects*; D008297:Male; D012254:Ribavirin / Q000008:administration & dosage / Q000009:adverse effects*
D000998:Antiviral Agents; D012254:Ribavirin; D007372:Interferons